These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 8469825)
1. [Myocardial hypertrophy and fibrosis]. Kawai S Kokyu To Junkan; 1993 Mar; 41(3):209-15. PubMed ID: 8469825 [No Abstract] [Full Text] [Related]
2. Myocardial fibrosis in nonhuman primate with pressure overload hypertrophy. Pick R; Janicki JS; Weber KT Am J Pathol; 1989 Nov; 135(5):771-81. PubMed ID: 2530905 [TBL] [Abstract][Full Text] [Related]
3. [Morphometric and stereological analysis of myocardial hypertrophy of different etiologies]. Nepomniashchikh LM; Lushnikova EL Vestn Akad Med Nauk SSSR; 1985; (1):65-74. PubMed ID: 3156455 [No Abstract] [Full Text] [Related]
6. [Myocardial hypertrophy in rabbits with vasorenal arterial hypertension during pharmacological blockade of formation of angiotensin II and its interaction with specific receptors]. Frolov VA; Drozdova GA; Mustiatsa VF; Balaev VV; Rieger P Biull Eksp Biol Med; 1999 May; 127(5):506-9. PubMed ID: 10399566 [No Abstract] [Full Text] [Related]
10. Effects of ACE inhibition versus non-ACE inhibitor antihypertensive treatment on myocardial fibrosis in patients with arterial hypertension. Retrospective analysis of 120 patients with left ventricular endomyocardial biopsies. Brilla CG; Rupp H; Maisch B Herz; 2003 Dec; 28(8):744-53. PubMed ID: 14689110 [TBL] [Abstract][Full Text] [Related]
11. Increased collagen deposition and diastolic dysfunction but preserved myocardial hypertrophy after pressure overload in mice lacking PKCepsilon. Klein G; Schaefer A; Hilfiker-Kleiner D; Oppermann D; Shukla P; Quint A; Podewski E; Hilfiker A; Schröder F; Leitges M; Drexler H Circ Res; 2005 Apr; 96(7):748-55. PubMed ID: 15761199 [TBL] [Abstract][Full Text] [Related]
12. Attenuation of ventricular hypertrophy and fibrosis in rats by pitavastatin: potential role of the RhoA-extracellular signal-regulated kinase-serum response factor signalling pathway. Saka M; Obata K; Ichihara S; Cheng XW; Kimata H; Noda A; Izawa H; Nagata K; Yokota M Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1164-71. PubMed ID: 17184496 [TBL] [Abstract][Full Text] [Related]
13. Overexpression of proadrenomedullin N-terminal 20 peptide blunts blood pressure rise and attenuates myocardial hypertrophy and fibrosis in hypertensive rats. Cao YN; Kuwasako K; Kato J; Nishihira K; Asada Y; Eto T; Kitamura K FEBS Lett; 2005 Sep; 579(22):4997-5001. PubMed ID: 16115629 [TBL] [Abstract][Full Text] [Related]
14. Biological characteristics of the myocardium during the regression of cardiac hypertrophy due to mechanical overload. Swynghedauw B; Chevalier B J Heart Valve Dis; 1995 Oct; 4 Suppl 2():S154-9. PubMed ID: 8563992 [No Abstract] [Full Text] [Related]
16. Osteopontin modulates angiotensin II-induced fibrosis in the intact murine heart. Collins AR; Schnee J; Wang W; Kim S; Fishbein MC; Bruemmer D; Law RE; Nicholas S; Ross RS; Hsueh WA J Am Coll Cardiol; 2004 May; 43(9):1698-705. PubMed ID: 15120833 [TBL] [Abstract][Full Text] [Related]
17. [Myocardial hypertrophy in atherosclerosis and hypertensive disease]. Antonchenko GP; Khaletskaia NI Arkh Patol; 1971; 33(1):52-7. PubMed ID: 4252266 [No Abstract] [Full Text] [Related]
19. Urotensin II accelerates cardiac fibrosis and hypertrophy of rats induced by isoproterenol. Zhang YG; Li YG; Liu BG; Wei RH; Wang DM; Tan XR; Bu DF; Pang YZ; Tang CS Acta Pharmacol Sin; 2007 Jan; 28(1):36-43. PubMed ID: 17184580 [TBL] [Abstract][Full Text] [Related]